National Health Investors (NHI) opened 2026 with Q1 Funds From Operations of US$59.8 million, or US$1.24 per share, setting the tone for how its cash generation is holding up as a health care focused REIT. Over the last few quarters, total revenue has moved from US$85.8 million in Q4 2024 to US$89.7 million in Q1 2025 and then to US$107.5 million in Q4 2025, while basic EPS over that same period ranged between US$0.75 and US$0.96, giving investors a clear look at how earnings track against the expanding top line. With consensus pointing to mid single to low double digit growth and an emphasis on cash based metrics like FFO, the latest release puts margins and cash yield firmly in focus for anyone assessing the current income profile.

See our full analysis for National Health Investors.

With the quarterly scorecard on the table, the next step is to see how these numbers line up against the widely followed bullish and bearish narratives around National Health Investors, and where the data pushes back on those stories.

FFO edges higher to US$59.8 million

• Q1 2026 Funds From Operations came in at US$59.8 million, with FFO per share at US$1.24, slightly above the US$58.5 million and US$1.23 per share recorded in Q4 2025. This shows that cash generation stayed solid even as reported EPS moved around last year.
• Consensus narrative points to senior housing demand and the SHOP portfolio as key drivers of long term earnings, and this quarter's FFO level partly lines up with that view but also shows some mixed signals:
  • On the supportive side, trailing 12 month FFO has reached US$226.1 million, up from US$218.7 million at the prior trailing point, which sits alongside forecasts for earnings to grow about 9.4% per year and revenue about 11.7% per year.
  • On the more cautious side, one year EPS growth of 3% is lower than the 5 year annual EPS growth rate of 4.7%, so the recent profit trend is not as strong as the longer term average that the bullish story leans on.

Margins soften while growth is still forecast

• Net profit margin over the last year is reported at 37.4%, compared with 41.1% the year before, at the same time as analysts expect revenue to grow about 11.7% per year and earnings about 9.4% per year, so investors are weighing margin pressure alongside growth expectations.
• Bears focus on margin pressure, tenant concentration and execution risks in the SHOP portfolio, and the margin data provides some support for that cautious stance:
  • Consensus narrative flags near term softness in occupancy and "abnormal move outs" in SHOP, and the drop in net margin from 41.1% to 37.4% fits with concerns that even small swings in occupancy or operating costs can move profitability for a health care REIT.
  • Critics also highlight reliance on a handful of tenants and on equity funding to grow, and with EPS over the last year rising 3% versus a 4.7% five year average, the slower recent EPS progression gives that bearish angle more weight.

On this margin picture, skeptics argue that the latest softness backs their concern about how quickly operating issues can feed through to earnings, so it can be useful to read the full bear case before deciding how much weight to put on these risks 🐻 National Health Investors Bear Case.

Mixed valuation signals around US$73 share price

• At a share price of US$73.09, NHI trades on a trailing P/E of 25x, which is below the cited peer average P/E of 59.2x but slightly above the Global Health Care REITs industry average of 24.5x. A DCF fair value of about US$172.79 and an analyst price target of US$88.75 both sit higher than the current price.
• Bullish investors point to that gap between price and value estimates, and the earnings and revenue outlook, as support for their view, although the numbers show a few tensions they still need to think about:
  • On the supportive side, the stock is indicated as trading about 57.7% below the DCF fair value of US$172.79 and consensus also implies upside from US$73.09 to the US$88.75 target, while trailing 12 month FFO per share of roughly US$4.76 suggests the business is still producing meaningful cash flow.
  • Balancing that, the same data set flags a high level of debt and an unstable dividend record, and with net margin moving from 41.1% to 37.4% over the last year, the bullish case needs those leverage and payout issues to stay manageable for the valuation gap to remain attractive.

Given those valuation gaps and the mix of growth forecasts and balance sheet flags, many investors will want to see how the upbeat case ties all these numbers together before forming a view on the stock 🐂 National Health Investors Bull Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for National Health Investors on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Seeing both risks and rewards in this story, it helps to move quickly and weigh the trade offs yourself using the 4 key rewards and 2 important warning signs.

Explore Alternatives

Recent figures highlight softer net margins, slower EPS growth than the 5 year average, and concerns around debt levels and an unstable dividend profile.

If those issues make you cautious, it is worth quickly checking the solid balance sheet and fundamentals stocks screener (46 results) so you can compare NHI with companies that have stronger financial footing and potentially steadier income streams.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.